Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.

Metra M, Pagnesi M, Claggett BL, Díaz R, Felker GM, McMurray JJV, Solomon SD, Bonderman D, Fang JC, Fonseca C, Fonseca C, Goncalvesova E, Howlett JG, Li J, O'Meara E, Miao ZM, Abbasi SA, Heitner SB, Kupfer S, Malik FI, Teerlink JR.

Open source

DOI: 10.1093/eurheartj/ehac293
Published: 2022-12-01
Container: Eur Heart J
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehac293,
  title = {Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.},
  author = {Metra M and  Pagnesi M and  Claggett BL and  Díaz R and  Felker GM and  McMurray JJV and  Solomon SD and  Bonderman D and  Fang JC and  Fonseca C and  Fonseca C and  Goncalvesova E and  Howlett JG and  Li J and  O'Meara E and  Miao ZM and  Abbasi SA and  Heitner SB and  Kupfer S and  Malik FI and  Teerlink JR.},
  year = {2022},
  journal = {Eur Heart J},
  doi = {10.1093/eurheartj/ehac293},
  url = {https://doi.org/10.1093/eurheartj/ehac293}
}

RIS

TY  - JOUR
TI  - Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.
AU  - Metra M
AU  -  Pagnesi M
AU  -  Claggett BL
AU  -  Díaz R
AU  -  Felker GM
AU  -  McMurray JJV
AU  -  Solomon SD
AU  -  Bonderman D
AU  -  Fang JC
AU  -  Fonseca C
AU  -  Fonseca C
AU  -  Goncalvesova E
AU  -  Howlett JG
AU  -  Li J
AU  -  O'Meara E
AU  -  Miao ZM
AU  -  Abbasi SA
AU  -  Heitner SB
AU  -  Kupfer S
AU  -  Malik FI
AU  -  Teerlink JR.
PY  - 2022
JO  - Eur Heart J
DO  - 10.1093/eurheartj/ehac293
UR  - https://doi.org/10.1093/eurheartj/ehac293
ER  -

APA

M, M., M, P., BL, C., R, D., GM, F., JJV, M., SD, S., D, B., JC, F., C, F., C, F., E, G., JG, H., J, L., E, O., ZM, M., SA, A., SB, H., S, K., FI, M., & JR., T. (2022). Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.. Eur Heart J. https://doi.org/10.1093/eurheartj/ehac293

Source records

europe-pmc · retrieved 2026-09-26T04:00:27.120Z